TriSalus Life Sciences, Inc. (TLSI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -6.48M | -2.48M | -3.71M | -7.32M | -4.5M | -5.71M | -10.85M | -13.42M | -10.87M | -8.85M | -21.66M | -9.24M |
| Operating CF Margin % | -72.82% | -18.81% | -32.07% | -65.28% | -49.08% | -69.08% | -147.6% | -182.27% | -168.3% | -154.68% | -417.14% | -200.26% |
| Operating CF Growth % | -44.03% | 56.47% | 65.81% | 45.46% | 58.6% | 35.51% | 49.93% | -45.32% | -3.47% | -6.49% | 5.32% | -14.1% |
| Net Income | 1.54M | -9.75M | -10.81M | -8.29M | -10.38M | -10.11M | -2.4M | -4.33M | -13.21M | -35.51M | -1.43M | -13.97M |
| Depreciation & Amortization | 135K | 126K | 163K | 165K | 172K | 193K | 182K | 194K | 175K | 202K | 286K | 150K |
| Stock-Based Compensation | 0 | 2.2M | 3.42M | 1.89M | 1.62M | 1.7M | 1.38M | 1.27M | 1.09M | 1M | 0 | 68K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -8.45M | 5.48M | 1.13M | 299K | 2.48M | 2.04M | -6.86M | -4.18M | 1.56M | 21.48M | -15.89M | 2.57M |
| Working Capital Changes | 296K | -530K | 2.39M | -1.39M | 1.6M | 467K | -3.15M | -6.38M | -483K | 3.98M | -4.63M | 1.95M |
| Change in Receivables | 1.29M | -1.59M | 497K | -174K | -366K | -361K | -206K | -429K | -723K | -502K | -940K | -502K |
| Change in Inventory | -701K | 199K | 531K | 355K | -114K | -48K | -556K | -531K | -368K | -915K | -107K | 199K |
| Change in Payables | 160K | 692K | 1.51M | 0 | 1.62M | 0 | 0 | 0 | -305K | 5.61M | -4.63M | 0 |
| Cash from Investing | -141K | -41K | -176K | 93K | -714K | -50K | -169K | -60K | -66K | -700K | -1.11M | -30K |
| Capital Expenditures | -141K | -41K | -216K | 93K | -754K | -50K | -169K | -60K | -66K | -372K | -112K | -31K |
| CapEx % of Revenue | 1.58% | 0.31% | 1.87% | 0.83% | 8.23% | 0.61% | 2.3% | 0.81% | 1.02% | 6.5% | 2.16% | 0.67% |
| Acquisitions | 0 | 0 | 40K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 40K | 0 | 0 | 0 | 0 | -328K | -1M | 1K |
| Cash from Financing | 42.38M | 277K | 82K | 20.72M | 9.69M | 2.99M | 5.82M | 25.99M | 3.13M | 43K | 40.25M | 6.4M |
| Debt Issued (Net) | -9K | -3K | -6K | -1K | 9.93M | -19K | -22K | 24.98M | -22K | -22K | -22K | -21K |
| Equity Issued (Net) | 42.66M | 280K | 88K | 22.21M | 0 | 2.95M | 5.84M | 3.6M | 3.14M | -9.63M | 4.54M | 6M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -263K | 0 | 0 | -1.49M | -241K | 62K | 2K | -2.59M | 7K | 9.7M | 35.74M | 422K |
| Net Change in Cash | 36.11M | -2.25M | -3.8M | 13.49M | 4.47M | -2.76M | -5.19M | 12.51M | -7.81M | -9.51M | 21.28M | -2.86M |
| Free Cash Flow | -6.62M | -2.52M | -3.92M | -7.23M | -5.25M | -5.76M | -11.02M | -13.48M | -10.93M | -9.55M | -21.84M | -9.27M |
| FCF Margin % | -74.4% | -19.12% | -33.94% | -64.45% | -57.3% | -69.69% | -149.9% | -183.08% | -169.32% | -166.91% | -420.57% | -200.91% |
| FCF Growth % | -26.04% | 56.14% | 64.37% | 46.4% | 51.95% | 39.71% | 49.56% | -45.5% | -3.37% | -11.27% | 6.39% | -12.66% |
| FCF per Share | -0.13 | -0.05 | -0.09 | -0.22 | -0.18 | -0.22 | -0.42 | -0.56 | -0.47 | -0.36 | -0.83 | -0.35 |
| FCF Conversion (FCF/Net Income) | -4.21x | 0.25x | 0.34x | 0.88x | 0.43x | 0.56x | 4.52x | 3.10x | 0.82x | 0.25x | 15.20x | 0.66x |
| Interest Paid | 0 | 0 | 0 | 848K | 709K | 0 | 0 | 448K | 3K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 15K | 1K | 0 | 0 | 4K | 0 | 0 | 0 | 0 |